
Corey S. Cutler, MD, MPH, FRCPC, Dana-Farber Cancer Institute
Advertisement
Articles by Corey S. Cutler, MD, MPH, FRCPC, Dana-Farber Cancer Institute
Advertisement
Advertisement
Advertisement
Trending on OncLive
1
FDA Grants Priority Review to Sonesitatug Vedotin in CLDN18.2+ Gastroesophageal Cancer
2
Dose Optimization, Evidentiary Bars, and Patient Selection Shape Trial Design in EGFR- and HER2-Mutant NSCLC
3
EC Approves Extended Cemiplimab Dosing in Skin, Lung, and Cervical Cancers
4
Defining High-Risk Localized Prostate Cancer and the DASL-HiCaP Trial
5




























